Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Filings indexed 804 across all filing types
Latest filing 2022-04-21 Regulatory Filings
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Najava sjednice Uprave 26.4.2022
Regulatory Filings Classification · 85% confidence The document is a formal announcement from MEDIKA d.d. dated April 21, 2022, titled "PREDMET – NAJAVA SJEDNICE UPRAVE DRUŠTVA" (SUBJECT – NOTICE OF MANAGEMENT BOARD MEETING). The content explicitly states that a Management Board meeting will be held on April 26, 2022, to discuss financial reports for the period 01.01.-31.03.2022 (Q1 2022). This is not the financial report itself, nor is it a transcript or a general regulatory filing. It is an announcement regarding an upcoming internal event where key management decisions or reviews (like financial results) will take place. This type of internal management communication, especially concerning the review of financial results before official release, best fits under Management Reports (MDA) or potentially a Regulatory Filing (RNS) if no other category fits. Since it specifically announces the management's review of financial results, MDA is a strong candidate, but given the context of announcing a meeting agenda rather than providing management's explanation of results, and considering the short length and nature of the announcement, it is most accurately classified as a general regulatory announcement or notice, which often falls under RNS if it doesn't fit the specific report types (like ER or IR). However, since the core subject is the management board meeting agenda, and it is not a standard earnings release (ER) or interim report (IR), it is a notice about management activity. Given the options, and that it is a formal notice to the market about management's agenda, RNS (Regulatory Filings - fallback) is the safest classification for a non-standard announcement, although it touches upon elements reviewed in MDA.
2022-04-21 Croatian
GFI POD Medika Grupa 31.12.2021. + napomena
Financial Supplement Data
2022-03-31 Croatian
Medika Grupa 2021 + napomena
Annual Report Classification · 100% confidence The document is a comprehensive 'Godišnje izvješće' (Annual Report) for Medika d.d. for the year ending December 31, 2021. It includes management reports, independent auditor's reports, consolidated financial statements (comprehensive income, financial position, cash flows), and notes to the financial statements. This matches the definition of a 10-K (Annual Report). FY 2021
2022-03-31 Croatian
GFI POD Medika d.d. + napomena
Financial Supplement Data
2022-03-31 Croatian
Medika d.d. 2021 + napomena
Annual Report Classification · 100% confidence The document is a comprehensive 'Annual Report' (Godišnje izvješće) for Medika d.d. for the fiscal year ending December 31, 2021. It includes the management report, independent auditor's report, financial statements (statement of financial position, comprehensive income, cash flows, changes in equity), and detailed notes to the financial statements. It is a full-length report containing substantive financial data, not an announcement or a summary. FY 2021
2022-03-31 Croatian
Najava GS 2.5.2022.
AGM Information Classification · 98% confidence The document explicitly states that the Management Board of Medika d.d. has convened a 'Glavnu skupštinu' (General Assembly/Meeting) for May 2, 2022. The text details the 'Dnevni red' (Agenda), which includes reviewing annual financial statements, approving management/supervisory board discharge, and authorizing the company to buy back its own shares. This content is characteristic of the materials prepared for and presented at an Annual General Meeting (AGM). Although it discusses annual results (related to 10-K/AR), the primary purpose and context of the document is the meeting itself and the resolutions to be voted upon. Therefore, the most appropriate classification is AGM Information (AGM-R).
2022-03-25 Croatian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.